IBDEI04W ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6269,2)
 ;;=^269038
 ;;^UTILITY(U,$J,358.3,6270,0)
 ;;=372.55^^36^400^19
 ;;^UTILITY(U,$J,358.3,6270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6270,1,3,0)
 ;;=3^Conjunctival Pigmentations
 ;;^UTILITY(U,$J,358.3,6270,1,4,0)
 ;;=4^372.55
 ;;^UTILITY(U,$J,358.3,6270,2)
 ;;=^269039
 ;;^UTILITY(U,$J,358.3,6271,0)
 ;;=372.61^^36^400^13
 ;;^UTILITY(U,$J,358.3,6271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6271,1,3,0)
 ;;=3^Conjunctiva,Granuloma
 ;;^UTILITY(U,$J,358.3,6271,1,4,0)
 ;;=4^372.61
 ;;^UTILITY(U,$J,358.3,6271,2)
 ;;=^269041
 ;;^UTILITY(U,$J,358.3,6272,0)
 ;;=372.64^^36^400^15
 ;;^UTILITY(U,$J,358.3,6272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6272,1,3,0)
 ;;=3^Conjunctiva,Scarring
 ;;^UTILITY(U,$J,358.3,6272,1,4,0)
 ;;=4^372.64
 ;;^UTILITY(U,$J,358.3,6272,2)
 ;;=^269044
 ;;^UTILITY(U,$J,358.3,6273,0)
 ;;=372.72^^36^400^38
 ;;^UTILITY(U,$J,358.3,6273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6273,1,3,0)
 ;;=3^Conjuntival Hemorrhage
 ;;^UTILITY(U,$J,358.3,6273,1,4,0)
 ;;=4^372.72
 ;;^UTILITY(U,$J,358.3,6273,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,6274,0)
 ;;=372.73^^36^400^18
 ;;^UTILITY(U,$J,358.3,6274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6274,1,3,0)
 ;;=3^Conjunctival Edema
 ;;^UTILITY(U,$J,358.3,6274,1,4,0)
 ;;=4^372.73
 ;;^UTILITY(U,$J,358.3,6274,2)
 ;;=^263899
 ;;^UTILITY(U,$J,358.3,6275,0)
 ;;=372.75^^36^400^17
 ;;^UTILITY(U,$J,358.3,6275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6275,1,3,0)
 ;;=3^Conjunctival Cysts
 ;;^UTILITY(U,$J,358.3,6275,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,6275,2)
 ;;=^269049
 ;;^UTILITY(U,$J,358.3,6276,0)
 ;;=372.89^^36^400^14
 ;;^UTILITY(U,$J,358.3,6276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6276,1,3,0)
 ;;=3^Conjunctiva,Lymphangiectasis
 ;;^UTILITY(U,$J,358.3,6276,1,4,0)
 ;;=4^372.89
 ;;^UTILITY(U,$J,358.3,6276,2)
 ;;=^321988
 ;;^UTILITY(U,$J,358.3,6277,0)
 ;;=376.12^^36^400^73
 ;;^UTILITY(U,$J,358.3,6277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6277,1,3,0)
 ;;=3^Orbital Myositis
 ;;^UTILITY(U,$J,358.3,6277,1,4,0)
 ;;=4^376.12
 ;;^UTILITY(U,$J,358.3,6277,2)
 ;;=^190915
 ;;^UTILITY(U,$J,358.3,6278,0)
 ;;=376.32^^36^400^72
 ;;^UTILITY(U,$J,358.3,6278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6278,1,3,0)
 ;;=3^Orbital Hemorrhage
 ;;^UTILITY(U,$J,358.3,6278,1,4,0)
 ;;=4^376.32
 ;;^UTILITY(U,$J,358.3,6278,2)
 ;;=^269185
 ;;^UTILITY(U,$J,358.3,6279,0)
 ;;=376.35^^36^400^81
 ;;^UTILITY(U,$J,358.3,6279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6279,1,3,0)
 ;;=3^Pulsating Exophthalmos
 ;;^UTILITY(U,$J,358.3,6279,1,4,0)
 ;;=4^376.35
 ;;^UTILITY(U,$J,358.3,6279,2)
 ;;=^269188
 ;;^UTILITY(U,$J,358.3,6280,0)
 ;;=376.36^^36^400^63
 ;;^UTILITY(U,$J,358.3,6280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6280,1,3,0)
 ;;=3^Lateral Displacement,Globe
 ;;^UTILITY(U,$J,358.3,6280,1,4,0)
 ;;=4^376.36
 ;;^UTILITY(U,$J,358.3,6280,2)
 ;;=^269190
 ;;^UTILITY(U,$J,358.3,6281,0)
 ;;=376.47^^36^400^89
 ;;^UTILITY(U,$J,358.3,6281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6281,1,3,0)
 ;;=3^Trauma/Surgery Deformity
 ;;^UTILITY(U,$J,358.3,6281,1,4,0)
 ;;=4^376.47
 ;;^UTILITY(U,$J,358.3,6281,2)
 ;;=^269203
 ;;^UTILITY(U,$J,358.3,6282,0)
 ;;=376.81^^36^400^70
 ;;^UTILITY(U,$J,358.3,6282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6282,1,3,0)
 ;;=3^Orbital Cysts
 ;;^UTILITY(U,$J,358.3,6282,1,4,0)
 ;;=4^376.81
 ;;^UTILITY(U,$J,358.3,6282,2)
 ;;=^269208
 ;;^UTILITY(U,$J,358.3,6283,0)
 ;;=376.82^^36^400^67
 ;;^UTILITY(U,$J,358.3,6283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6283,1,3,0)
 ;;=3^Myopathy Extraocular Muscles
 ;;^UTILITY(U,$J,358.3,6283,1,4,0)
 ;;=4^376.82
 ;;^UTILITY(U,$J,358.3,6283,2)
 ;;=^269209
 ;;^UTILITY(U,$J,358.3,6284,0)
 ;;=376.9^^36^400^71
 ;;^UTILITY(U,$J,358.3,6284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6284,1,3,0)
 ;;=3^Orbital D/O,Unspec
 ;;^UTILITY(U,$J,358.3,6284,1,4,0)
 ;;=4^376.9
 ;;^UTILITY(U,$J,358.3,6284,2)
 ;;=^86142
 ;;^UTILITY(U,$J,358.3,6285,0)
 ;;=379.29^^36^400^94
 ;;^UTILITY(U,$J,358.3,6285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6285,1,3,0)
 ;;=3^Vitreous D/O,Oth
 ;;^UTILITY(U,$J,358.3,6285,1,4,0)
 ;;=4^379.29
 ;;^UTILITY(U,$J,358.3,6285,2)
 ;;=^269314
 ;;^UTILITY(U,$J,358.3,6286,0)
 ;;=694.61^^36^400^76
 ;;^UTILITY(U,$J,358.3,6286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6286,1,3,0)
 ;;=3^Pemphigoid Bgn Mucous Membr w/ Ocular
 ;;^UTILITY(U,$J,358.3,6286,1,4,0)
 ;;=4^694.61
 ;;^UTILITY(U,$J,358.3,6286,2)
 ;;=^271915
 ;;^UTILITY(U,$J,358.3,6287,0)
 ;;=720.0^^36^400^85
 ;;^UTILITY(U,$J,358.3,6287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6287,1,3,0)
 ;;=3^Spondylitis,Ankylosing
 ;;^UTILITY(U,$J,358.3,6287,1,4,0)
 ;;=4^720.0
 ;;^UTILITY(U,$J,358.3,6287,2)
 ;;=^113484
 ;;^UTILITY(U,$J,358.3,6288,0)
 ;;=743.10^^36^400^66
 ;;^UTILITY(U,$J,358.3,6288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6288,1,3,0)
 ;;=3^Microphthalmos,Unspec
 ;;^UTILITY(U,$J,358.3,6288,1,4,0)
 ;;=4^743.10
 ;;^UTILITY(U,$J,358.3,6288,2)
 ;;=^77633
 ;;^UTILITY(U,$J,358.3,6289,0)
 ;;=996.89^^36^400^52
 ;;^UTILITY(U,$J,358.3,6289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6289,1,3,0)
 ;;=3^Graft Rejection
 ;;^UTILITY(U,$J,358.3,6289,1,4,0)
 ;;=4^996.89
 ;;^UTILITY(U,$J,358.3,6289,2)
 ;;=^276309
 ;;^UTILITY(U,$J,358.3,6290,0)
 ;;=077.3^^36^400^26
 ;;^UTILITY(U,$J,358.3,6290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6290,1,3,0)
 ;;=3^Conjunctivitis,Adenoviral
 ;;^UTILITY(U,$J,358.3,6290,1,4,0)
 ;;=4^077.3
 ;;^UTILITY(U,$J,358.3,6290,2)
 ;;=^266673
 ;;^UTILITY(U,$J,358.3,6291,0)
 ;;=077.99^^36^400^21
 ;;^UTILITY(U,$J,358.3,6291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6291,1,3,0)
 ;;=3^Conjunctivitis d/t Virus,Unspec
 ;;^UTILITY(U,$J,358.3,6291,1,4,0)
 ;;=4^077.99
 ;;^UTILITY(U,$J,358.3,6291,2)
 ;;=^295786
 ;;^UTILITY(U,$J,358.3,6292,0)
 ;;=077.98^^36^400^9
 ;;^UTILITY(U,$J,358.3,6292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6292,1,3,0)
 ;;=3^Conjuctivitis d/t Chlamydiae
 ;;^UTILITY(U,$J,358.3,6292,1,4,0)
 ;;=4^077.98
 ;;^UTILITY(U,$J,358.3,6292,2)
 ;;=^295785
 ;;^UTILITY(U,$J,358.3,6293,0)
 ;;=190.4^^36^400^40
 ;;^UTILITY(U,$J,358.3,6293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6293,1,3,0)
 ;;=3^Cornea Malig Neopl
 ;;^UTILITY(U,$J,358.3,6293,1,4,0)
 ;;=4^190.4
 ;;^UTILITY(U,$J,358.3,6293,2)
 ;;=^267275
 ;;^UTILITY(U,$J,358.3,6294,0)
 ;;=V67.09^^36^401^22
 ;;^UTILITY(U,$J,358.3,6294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6294,1,3,0)
 ;;=3^F/U Vitreous Surgery
 ;;^UTILITY(U,$J,358.3,6294,1,4,0)
 ;;=4^V67.09
 ;;^UTILITY(U,$J,358.3,6294,2)
 ;;=F/U Vitreous Surgery^322080^V45.69^V43.1
 ;;^UTILITY(U,$J,358.3,6295,0)
 ;;=367.4^^36^401^43
 ;;^UTILITY(U,$J,358.3,6295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6295,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,6295,1,4,0)
 ;;=4^367.4
 ;;^UTILITY(U,$J,358.3,6295,2)
 ;;=Presbyopia^98095
 ;;^UTILITY(U,$J,358.3,6296,0)
 ;;=379.21^^36^401^42
 ;;^UTILITY(U,$J,358.3,6296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6296,1,3,0)
 ;;=3^Posterior Vitreous Detachment
 ;;^UTILITY(U,$J,358.3,6296,1,4,0)
 ;;=4^379.21
 ;;^UTILITY(U,$J,358.3,6296,2)
 ;;=^269309
 ;;^UTILITY(U,$J,358.3,6297,0)
 ;;=374.10^^36^401^20
 ;;^UTILITY(U,$J,358.3,6297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6297,1,3,0)
 ;;=3^Ectropion
 ;;^UTILITY(U,$J,358.3,6297,1,4,0)
 ;;=4^374.10
 ;;^UTILITY(U,$J,358.3,6297,2)
 ;;=Ectropion^38326
 ;;^UTILITY(U,$J,358.3,6298,0)
 ;;=373.00^^36^401^8
 ;;^UTILITY(U,$J,358.3,6298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6298,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,6298,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,6298,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,6299,0)
 ;;=250.00^^36^401^13
 ;;^UTILITY(U,$J,358.3,6299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6299,1,3,0)
 ;;=3^DM II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,6299,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6299,2)
 ;;=DM Type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,6300,0)
 ;;=250.50^^36^401^12
 ;;^UTILITY(U,$J,358.3,6300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6300,1,3,0)
 ;;=3^DM II w/PDR
 ;;^UTILITY(U,$J,358.3,6300,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,6300,2)
 ;;=DM II w/PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,6301,0)
 ;;=375.15^^36^401^19
 ;;^UTILITY(U,$J,358.3,6301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6301,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,6301,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,6301,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,6302,0)
 ;;=368.40^^36^401^50
 ;;^UTILITY(U,$J,358.3,6302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6302,1,3,0)
 ;;=3^Visual Field Defect,Unspec
 ;;^UTILITY(U,$J,358.3,6302,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,6302,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,6303,0)
 ;;=366.53^^36^401^3
 ;;^UTILITY(U,$J,358.3,6303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6303,1,3,0)
 ;;=3^After Cataract Obscurring Vision
 ;;^UTILITY(U,$J,358.3,6303,1,4,0)
 ;;=4^366.53
 ;;^UTILITY(U,$J,358.3,6303,2)
 ;;=After Cataract Obscurring Vision^268823
 ;;^UTILITY(U,$J,358.3,6304,0)
 ;;=366.9^^36^401^10
 ;;^UTILITY(U,$J,358.3,6304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6304,1,3,0)
 ;;=3^Cataract, Unspecified
 ;;^UTILITY(U,$J,358.3,6304,1,4,0)
 ;;=4^366.9
 ;;^UTILITY(U,$J,358.3,6304,2)
 ;;=Cataract, Unspecified^20266
 ;;^UTILITY(U,$J,358.3,6305,0)
 ;;=362.83^^36^401^34
 ;;^UTILITY(U,$J,358.3,6305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6305,1,3,0)
 ;;=3^Macular Edema (CSME)
 ;;^UTILITY(U,$J,358.3,6305,1,4,0)
 ;;=4^362.83
 ;;^UTILITY(U,$J,358.3,6305,2)
 ;;=Macular Edema^89576
 ;;^UTILITY(U,$J,358.3,6306,0)
 ;;=362.52^^36^401^11
 ;;^UTILITY(U,$J,358.3,6306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6306,1,3,0)
 ;;=3^Cystoid Macular Degeneration
 ;;^UTILITY(U,$J,358.3,6306,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,6306,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,6307,0)
 ;;=367.22^^36^401^32
